◀ Back to IL3

EGR1 — IL3

Text-mined interactions from Literome

DU et al., Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008 : It is concluded that these in vitro data provide an experimental basis for the use of gene therapy of hematopoietic growth factor gene regulated by Egr-1 promoter to protect hematopoiesis from ADM-injury
DU et al., Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009 : This study was purposed to investigate the effect of hematopoietic growth factor expression regulated by Egr-1 promoter on the recovery of hematopoietic function in bearing-melanoma mice after chemotherapy with doxorubicin ( ADM )
Du et al., Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2009 : The therapy of hematopoietic growth factor gene regulated by Egr-1 promoter can protect hematopoiesis from 5-Fu injury
Du et al., Zhonghua Yi Xue Za Zhi 2009 : These in vitro data provide an experimental basis for use of gene therapy of hematopoietic growth factor gene regulated by Egr-1 promoter to protect hematopoiesis from 5-Fu-injury effects
Koyano-Nakagawa et al., Mol Cell Biol 1994 : EGR1 and EGR2 increased IL-3 promoter activity when the transfected cells were stimulated with phorbol-12-myristate-13-acetate and A23187
Sakamoto et al., Mol Cell Biol 1994 : Both GM-CSF and IL-3 rapidly and transiently induce expression of early growth response gene 1 (egr-1) in the human factor dependent cell line TF-1
Liu et al., Cell Growth Differ 1993 (Carcinoma, Hepatocellular...) : Other similar cytokines were investigated, and, of these, only interleukin 1 could increase both Egr-1 and LDL receptor activity